Thermo Fisher Scientific Further Expands COVID-19 Test Portfolio with Two New Antibody Tests

Thermo Fisher Scientific Inc. introduces two new SARS-CoV-2 antibody tests: the Thermo Scientific OmniPATH COVID-19 Total Antibody ELISA test, and the Thermo Scientific EliA SARS-CoV-2-Sp1 IgG test. These new tests for detecting COVID-19 antibodies expand the company’s leading response to the pandemic, which ranges from molecular diagnostic tests and sample collection products, to personal protective equipment, to support of therapy and vaccine development and manufacturing.

[Read More]

Please to read the entire article.

You must be logged in to post a comment Login